These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22172440)

  • 21. Long-Term Outcomes of a Comprehensive Mobile Smoking Cessation Program With Nicotine Replacement Therapy in Adult Smokers: Pilot Randomized Controlled Trial.
    Marler JD; Fujii CA; Utley MT; Balbierz DJ; Galanko JA; Utley DS
    JMIR Mhealth Uhealth; 2023 Sep; 11():e48157. PubMed ID: 37585282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal effects of smoking cessation on carotid artery atherosclerosis in contemporary smokers: The Wisconsin Smokers Health Study.
    Stein JH; Smith SS; Hansen KM; Korcarz CE; Piper ME; Fiore MC; Baker TB
    Atherosclerosis; 2020 Dec; 315():62-67. PubMed ID: 33227549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?
    Choi SH; Terrell JE; Bradford CR; Ghanem T; Spector ME; Wolf GT; Lipkus IM; Duffy SA
    Nicotine Tob Res; 2016 Dec; 18(12):2216-2224. PubMed ID: 27613928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events.
    Yang Y; Peng N; Chen G; Wan Q; Yan L; Wang G; Qin Y; Luo Z; Tang X; Huo Y; Hu R; Ye Z; Qin G; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Chen L; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Li M; Xu Y; Xu M; Zhao Z; Wang T; Lu J; Bi Y; Wang W; Ning G; Zhang Q; Shi L
    Cardiovasc Diabetol; 2022 Jan; 21(1):14. PubMed ID: 35073925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.
    Rink M; Furberg H; Zabor EC; Xylinas E; Babjuk M; Pycha A; Lotan Y; Karakiewicz PI; Novara G; Robinson BD; Montorsi F; Chun FK; Scherr DS; Shariat SF
    Eur Urol; 2013 Apr; 63(4):724-32. PubMed ID: 22925575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.
    Taylor AH; Thompson TP; Streeter A; Chynoweth J; Snowsill T; Ingram W; Ussher M; Aveyard P; Murray RL; Harris T; Green C; Horrell J; Callaghan L; Greaves CJ; Price L; Cartwright L; Wilks J; Campbell S; Preece D; Creanor S
    Health Technol Assess; 2023 Mar; 27(4):1-277. PubMed ID: 37022933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.
    Cox LS; Nollen NL; Mayo MS; Choi WS; Faseru B; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS
    J Natl Cancer Inst; 2012 Feb; 104(4):290-8. PubMed ID: 22282543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking cessation and the risk of diabetes mellitus and impaired fasting glucose: three-year outcomes after a quit attempt.
    Stein JH; Asthana A; Smith SS; Piper ME; Loh WY; Fiore MC; Baker TB
    PLoS One; 2014; 9(6):e98278. PubMed ID: 24893290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial.
    King A; Cao D; Zhang L; Rueger SY
    Addiction; 2013 Oct; 108(10):1836-44. PubMed ID: 23714324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in carotid artery structure with smoking cessation.
    Mitchell C; Piper ME; Smith SS; Korcarz CE; Fiore MC; Baker TB; Stein JH
    Vasc Med; 2019 Dec; 24(6):493-500. PubMed ID: 31422759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women.
    Korhonen T; Goodwin A; Miesmaa P; Dupuis EA; Kinnunen T
    J Womens Health (Larchmt); 2011 Jul; 20(7):1051-64. PubMed ID: 21675876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease.
    Thorndike AN; Regan S; McKool K; Pasternak RC; Swartz S; Torres-Finnerty N; Rigotti NA
    Arch Intern Med; 2008 Jan; 168(2):186-91. PubMed ID: 18227366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.
    Tonstad S; Farsang C; Klaene G; Lewis K; Manolis A; Perruchoud AP; Silagy C; van Spiegel PI; Astbury C; Hider A; Sweet R
    Eur Heart J; 2003 May; 24(10):946-55. PubMed ID: 12714026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of smoking cessation in adolescents.
    Sargent JD; Mott LA; Stevens M
    Arch Pediatr Adolesc Med; 1998 Apr; 152(4):388-93. PubMed ID: 9559717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United States.
    Inoue-Choi M; Christensen CH; Rostron BL; Cosgrove CM; Reyes-Guzman C; Apelberg B; Freedman ND
    JAMA Netw Open; 2020 Jun; 3(6):e206436. PubMed ID: 32492162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking cessation for secondary prevention of cardiovascular disease.
    Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's initiative for nonsmoking (WINS) IV: description of 277 women smokers hospitalized with cardiovascular disease.
    Froelicher ES; Christopherson DJ; Miller NH; Martin K
    Heart Lung; 2002; 31(1):3-14. PubMed ID: 11805744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy--clinical effectiveness and safety until 2 years after delivery, with economic evaluation.
    Cooper S; Lewis S; Thornton JG; Marlow N; Watts K; Britton J; Grainge MJ; Taggar J; Essex H; Parrott S; Dickinson A; Whitemore R; Coleman T;
    Health Technol Assess; 2014 Aug; 18(54):1-128. PubMed ID: 25158081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler.
    Kralikova E; Kozak JT; Rasmussen T; Gustavsson G; Le Houezec J
    BMC Public Health; 2009 Nov; 9():433. PubMed ID: 19943947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.